B. Research - Clemenceau Medical Center

advertisement
Wael AlJaroudi, MD
Curriculum Vitae
A. Personal Experience
1.
Personal Information
Wael AlJaroudi, MD, MS, RPVI, FACC, FAHA, FASE, FASNC, FSCCT
Associate Professor of Medicine
Clemenceau Medical Center
Beirut, Lebanon
(w): +961-1-372888, ext 1170/1171
(c) +961-3-839383
e(h) 216-751-0409
Email: wael.jaroudi@cmc.com.lb; wjaroudi@hotmail.com
Languages: English, Arabic, French
2.
Educational Background
INSTITUTION AND LOCATION
American University of Beirut, Beirut, Lebanon
American University of Beirut Medical School, Beirut, Lebanon
American University of Beirut, Beirut, Lebanon
Duke University Medical Center, Durham, NC
Duke University Medical Center, Division of Cardiovascular Magnetic
Resonance Center, Durham, NC
University of Alabama at Birmingham, Birmingham, AL
DEGREE
YEAR(s)
B.S
M.D.
M.S
Residency
Fellowship
1995-1998
1998-2002
2002-2003
2003-2006
2006-2007
Chemistry
Medicine
Physiology
Internal Medicine
Cardiac MRI fellowship
Fellowship
2007-2010
Cardiovascular Disease
FIELD OF STUDY
Boards and certificates
2006
2008
2009
2009
2009
2010
2010
2010
2010
2010
2011
2014
American Board of Internal Medicine (recertified April 2015)
Registered Physician in Vascular Interpretation
Diplomate, Clinical Lipidology
Specialist in Clinical Hypertension
American Board of Echocardiography
American Board of Nuclear cardiology
American Board of Cardiac CT
American Board of Cardiology
Level III Cardiac CT
Level III Nuclear Cardiology
Level III Cardiac MRI (Society of CMR)
Grandfathered Level III CMR (European Association of CV imaging)
Honors and Awards
1
2014
2014
2014
2012
2010
2010
2005
2004
2002
2002
2002
2001
1999- 2002
1998
1998
1996-1998
3.
Recognition by the American College of Cardiology for the time and
commitment for serving as CardioSurv Panelist
Best Ranked Abstract from Lebanon submitted to the American College
Cardiology of 2014
Farouk Jabre Biomedical Research Award (co-PI)
Distinguished Teacher Award, Cleveland Clinic
Best Research Fellow, University of Alabama at Birmingham
Alabama American College Cardiology Research Award
Primer Research Award, Duke University Medical Center
Best Research Award, American College of Physician/ North Carolina
Graduated with Distinction (MD)
Penrose Award, Faculty of Medicine
Middle East Medical Assembly (MEMA) Research Award
Alpha Omega Alpha Research Award
Dean’s Honor List, Faculty of Medicine
Graduated with High Distinction (BS)
Penrose Award, Faculty of Arts and Sciences
Dean’s Honor List, Faculty of Arts and Sciences
Work Experience
Academic Appointments:
7/2015-Present: Associate Professor of Medicine and Diagnostic Radiology, Cardiovascular
Medicine, Clemenceau Medical Center, Beirut, Lebanon
1/2013-7/2015: Assistant Professor of Medicine and Radiology, Cardiovascular Medicine,
American University of Beirut Medical Center, Beirut, Lebanon
8/2010-12/2012 Assistant Professor of Medicine, Staff in Cardiology and Radiology,
Cardiovascular Medicine, Section of Cardiovascular Imaging, Heart & Vascular Institute, Cleveland
Clinic Foundation, Cleveland, OH
Administrative Appointments:
7/2015-Present: Director, Cardiovascular Imaging, Clemenceau Medical Center, Beirut, Lebanon
1/2013-7/2015: Director, Cardiology Fellowship Program, American University of Beirut Medical
Center, Beirut, Lebanon
B. Research
Research Support
1.
“Prevalence, Predictors and Prognostic Value of Diastolic Dysfunction in the Lebanese and
Middle Eastern Population”
Funding source: AUBMC Seed Grant
Amount: 22,000 USD
Year: July 1st 2013-June 30th 2014
Role: Primary Investigator
2
2.
“Noninvasive Linear Accelerator-Based Stereotactic Radiotherapy for Atrioventricular Node
Ablation”: Awarded 2014 Farouk Jabre Biomedical Research Award
Funding source: Approved.
Amount: 33,000 USD
Year: July 2014-June 2015
Role: Co-Investigator
3.
“Left Ventricular Dyssynchrony by Phase Analysis is a Predictor of Cardiovascular Outcome in
Patients with LV Dysfunction”
Funding source: National Clinical research program 11CRP5180029; American Heart Association
Amount: 100,000 USD
Year: 1/1/2011-12/31/2012.
Role: PI
4.
“Role of LV Synchrony Assessment by Nuclear Perfusion SPECT”.
Funding: Cleveland Clinic Research Projects Committee RPC
Amount: 40,000 USD
Year: 7/31/10 to 7/31/11.
Role: PI
Selected Journal Publications:
1.
AlJaroudi W, Refaat MM, Habib R, Al-Shaar L, Singh M, Gutmann R, Bloom H, Dudley S, Ellinor P,
Saba S, Shalaby A, Weiss R, McNamara D, Halder I, London B. Effect of ACEi and ARB on appropriate
ICD shock in patients with severe systolic heart failure (from the GRADE multicenter study). Am J
Cardiol 2015;115:924-31. (First author, original paper, impact factor 3.6).
2.
Abchee A, Skouri H, Matta S, El-Masri L, Alraies C, AlJaroudi W. Prevalence and Predictors of
worsening of diastolic function in cancer patients with normal baseline ejection fraction undergoing
chemotherapy. J Clin Exp Cardiolog 2014,5:10 (http://dx.doi.org/10.4172/2155-9880.1000349)
(Senior and corresponding author, original paper, Impact factor 2.029).
3.
AlJaroudi W, Desai M, Tang W, Phelan D, Cerqueira M, Jaber W. Role of imaging in the diagnosis and
management of patients with cardiac amyloidosis: State of the art review and focus on emerging
nuclear techniques. J Nucl Cardiol 2014;21:271-83 (First and corresponding author, Review paper,
Impact factor 2.7).
4.
AlJaroudi WA, Thomas JD, Rodriguez LL, Jaber WA. Prognostic value of diastolic dysfunction: State of
Art Review. Cardiology in review 2014;22:79-90 (first & corresponding author, review paper,
Impact Factor 3.1)
5.
AlJaroudi W. Early post-stress LV dyssynchrony: A new marker for significant CAD. J Nucl Cardiol.
2014 (Editorial, first and corresponding author, impact factor 2.7).
6.
AlJaroudi WA, Alraies MC, Halley C, Rodriguez L, Grimm RA, Thomas JD, Jaber WA. Effect of age,
gender, and left ventricular diastolic function on left atrial volume index in adults without known
cardiovascular disease or risk factors. Am J Cardiol 2013;111:1517-1522 (first and corresponding
author, original manuscript, Impact factor 3.6)
3
7.
AlJaroudi WA, Alraies MC, Cerqueira MD, Jaber MD. Safety and Tolerability of Regadenoson in 514
SPECT MPI Patients with and without Coronary Artery Disease and Submaximal Exercise Heart Rate
Response. Eur J Nuc Mol Img 2013;40:341-348 (first and corresponding author, original manuscript,
Impact factor 5.0)
8.
AlJaroudi WA, Alraies MC, Wazni O, Cerqueira M, Jaber WA. Yield and diagnostic value of stress
myocardial perfusion in patients without known coronary artery disease presenting with syncope.
Circ Cardiovasc Imaging. 2013;6:384-91 (first and corresponding author, original manuscript,
Impact factor 5.9)
9.
AlJaroudi WA, Flamm S, Saliba W, Wilkoff B, Kwon B. Role of Cardiac Magnetic Resonance Imaging in
Risk Stratification of Sudden Cardiac Death: State of the Art Review, JACC: CV imaging, 2013;6:392406 (first and corresponding author, review paper, Impact factor 5.8)
10. AlJaroudi W, Alraies MC, Halley C, Rodriguez L, Grimm R, Thomas J, Jaber W. Impact of progression
of diastolic dysfunction on mortality in patients with normal systolic function. Circulation, 2012,
;125:782-8 (first and corresponding author, original manuscript, Impact factor 15.2)
4
Download